Abstract
Obesity is a key player in the onset and progression of insulin resistance (IR), a state by which insulin-sensitive cells fail to adequately respond to insulin action. IR is a reversible condition, but if untreated leads to type 2 diabetes alongside increasing cardiovascular risk. The link between obesity and IR has been widely investigated; however, some aspects are still not fully characterized.
In this chapter, we introduce key aspects of the pathophysiology of IR and its intimate connection with obesity. Specifically, we focus on the role of adipose tissue dysfunction (quantity, quality, and distribution) as a driver of whole-body IR. Furthermore, we discuss the obesity-related lipidomic remodeling occurring in adipose tissue, liver, and skeletal muscle. Key mechanisms linking lipotoxicity to IR in different tissues and metabolic alterations (i.e., fatty liver and diabetes) and the effect of weight loss on IR are also reported while highlighting knowledge gaps.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30(1):89–94. https://doi.org/10.2337/dc06-1519
Adams JM 2nd, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53(1):25–31. https://doi.org/10.2337/diabetes.53.1.25
Alligier M, Gabert L, Meugnier E et al (2013) Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J Clin Endocrinol Metab 98(2):802–810. https://doi.org/10.1210/jc.2012-3289
Amati F, Dube JJ, Alvarez-Carnero E et al (2011) Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60(10):2588–2597. https://doi.org/10.2337/db10-1221
Anastasiou CA, Kavouras SA, Lentzas Y, Gova A, Sidossis LS, Melidonis A (2009) Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism 58(11):1636–1642. https://doi.org/10.1016/j.metabol.2009.05.019
Anderson RL, Hamman RF, Savage PJ et al (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The insulin resistance atherosclerosis study. Am J Epidemiol 142(7):724–732. https://doi.org/10.1093/aje/142.7.724
Arner E, Westermark PO, Spalding KL et al (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59(1):105–109. https://doi.org/10.2337/db09-0942
Arner P, Bernard S, Salehpour M et al (2011) Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478(7367):110–113. https://doi.org/10.1038/nature10426
Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A (2020) Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology 158(7):1899–1912. https://doi.org/10.1053/j.gastro.2019.12.054
Bastard JP, Faraj M, Karelis AD et al (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test: response to Abdul-Ghani et al. Diabetes Care 30(7):e83; author reply e84. https://doi.org/10.2337/dc07-0622
Bedogni G, Gastaldelli A, Manco M et al (2012) Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis 22(2):120–126. https://doi.org/10.1016/j.numecd.2010.05.003
Belfiore F, Iannello S, Volpicelli G (1998) Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63(2):134–141. https://doi.org/10.1006/mgme.1997.2658
Bell LN, Wang J, Muralidharan S et al (2012) Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology 56(4):1311–1318. https://doi.org/10.1002/hep.25805
Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14–23. https://doi.org/10.1046/j.1365-2362.32.s3.3.x
Boden G, Chen X, Iqbal N (1998) Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 47(10):1609–1612. https://doi.org/10.2337/diabetes.47.10.1609
Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA (1990) Obesity and insulin resistance in humans: a dose-response study. Metabolism 39(5):452–459. https://doi.org/10.1016/0026-0495(90)90002-t
Bourbon NA, Sandirasegarane L, Kester M (2002) Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 277(5):3286–3292. https://doi.org/10.1074/jbc.M110541200
Brandon AE, Liao BM, Diakanastasis B et al (2019) Protein kinase C epsilon deletion in adipose tissue, but not in liver, improves glucose tolerance. Cell Metab 29(1):183–191 e187. https://doi.org/10.1016/j.cmet.2018.09.013
Bril F, Barb D, Portillo-Sanchez P et al (2017) Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 65(4):1132–1144. https://doi.org/10.1002/hep.28985
Brouwers B, Schrauwen-Hinderling VB, Jelenik T et al (2017) Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. Clin Sci (Lond) 131(15):1905–1917. https://doi.org/10.1042/CS20170261
Bugianesi E, Gastaldelli A, Vanni E et al (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48(4):634–642. https://doi.org/10.1007/s00125-005-1682-x
Camastra S, Gastaldelli A, Mari A et al (2011) Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 54(8):2093–2102. https://doi.org/10.1007/s00125-011-2193-6
Chaurasia B, Kaddai VA, Lancaster GI et al (2016) Adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism. Cell Metab 24(6):820–834. https://doi.org/10.1016/j.cmet.2016.10.002
Chavez JA, Knotts TA, Wang LP et al (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278(12):10297–10303. https://doi.org/10.1074/jbc.M212307200
Choromanska B, Mysliwiec P, Razak Hady H et al (2019) Metabolic syndrome is associated with ceramide accumulation in visceral adipose tissue of women with morbid obesity. Obesity (Silver Spring) 27(3):444–453. https://doi.org/10.1002/oby.22405
Coen PM, Dube JJ, Amati F et al (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59(1):80–88. https://doi.org/10.2337/db09-0988
Coen PM, Hames KC, Leachman EM et al (2013) Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity. Obesity (Silver Spring) 21(11):2362–2371. https://doi.org/10.1002/oby.20381
Cusi K, Maezono K, Osman A et al (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105(3):311–320. https://doi.org/10.1172/JCI7535
Dadson P, Ferrannini E, Landini L et al (2017) Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery. Am J Physiol Endocrinol Metab 313(2):E175–E182. https://doi.org/10.1152/ajpendo.00044.2017
Davidson LE, Yu W, Goodpaster BH et al (2018) Fat-free mass and skeletal muscle mass five years after bariatric surgery. Obesity 26(7):1130–1136. https://doi.org/10.1002/oby.22190
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214–E223. https://doi.org/10.1152/ajpendo.1979.237.3.E214
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343–1351. https://doi.org/10.1172/JCI23621
Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J (1995) A simple measure of insulin resistance. Lancet 346(8967):120–121. https://doi.org/10.1016/s0140-6736(95)92143-5
Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106(36):15430–15435. https://doi.org/10.1073/pnas.0904944106
Fabbrini E, Sullivan S, Klein S (2010a) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2):679–689. https://doi.org/10.1002/hep.23280
Fabbrini E, Tamboli RA, Magkos F et al (2010b) Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 139(2):448–455. https://doi.org/10.1053/j.gastro.2010.04.056
Fabbrini E, Magkos F, Conte C et al (2012) Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res 53(2):321–324. https://doi.org/10.1194/jlr.D020321
Fredrikson G, Tornqvist H, Belfrage P (1986) Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid. Metabolism 876(2):288–293. https://doi.org/10.1016/0005-2760(86)90286-9
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5(5):1544–1560. https://doi.org/10.3390/nu5051544
Gaggini M, Carli F, Gastaldelli A (2017) The color of fat and its central role in the development and progression of metabolic diseases. Horm Mol Biol Clin Invest 31(1). https://doi.org/10.1515/hmbci-2017-0060
Garg A (2011) Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 96(11):3313–3325. https://doi.org/10.1210/jc.2011-1159
Gastaldelli A (2011) Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Diabetes Res Clin Pract 93(Suppl 1):S60–S65. https://doi.org/10.1016/S0168-8227(11)70015-8
Gastaldelli A, Ferrannini E (2014) Chapter 3: pathophysiology of prediabetes: role of lipotoxicity? In: Bergman M (ed) Global health perspectives in prediabetes and diabetes prevention, vol 1. World Scientific, Hackensack, pp 31–48
Gastaldelli A, Baldi S, Pettiti M et al (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49(8):1367–1373. https://doi.org/10.2337/diabetes.49.8.1367
Gastaldelli A, Miyazaki Y, Pettiti M et al (2002) Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87(11):5098–5103. https://doi.org/10.1210/jc.2002-020696
Gastaldelli A, Sironi AM, Ciociaro D et al (2005) Visceral fat and beta cell function in non-diabetic humans. Diabetologia 48(10):2090–2096. https://doi.org/10.1007/s00125-005-1891-3
Gastaldelli A, Cusi K, Pettiti M et al (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133(2):496–506. https://doi.org/10.1053/j.gastro.2007.04.068
Gastaldelli A, Harrison SA, Belfort-Aguilar R et al (2009) Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50(4):1087–1093. https://doi.org/10.1002/hep.23116
Gastaldelli A, Gaggini M, DeFronzo RA (2017) Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study. Diabetes 66(4):815–822. https://doi.org/10.2337/db16-1167
Gastaldelli A, Sabatini S, Carli F et al (2021) PPAR-gamma-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver Int. https://doi.org/10.1111/liv.15005
Greco AV, Mingrone G, Giancaterini A et al (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51(1):144–151. https://doi.org/10.2337/diabetes.51.1.144
Griffin JL, Atherton H, Shockcor J, Atzori L (2011) Metabolomics as a tool for cardiac research. Nat Rev Cardiol 8(11):630–643. https://doi.org/10.1038/nrcardio.2011.138
Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84(1):205–213. https://doi.org/10.1172/JCI114142
Guo ZK, Cella LK, Baum C, Ravussin E, Schoeller DA (2000) De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry. Int J Obes Relat Metab Disord 24(7):932–937. https://doi.org/10.1038/sj.ijo.0801256
Haemmerle G, Zimmermann R, Hayn M et al (2002) Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277(7):4806–4815. https://doi.org/10.1074/jbc.M110355200
Haemmerle G, Lass A, Zimmermann R et al (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312(5774):734–737. https://doi.org/10.1126/science.1123965
Hansen T, Drivsholm T, Urhammer SA et al (2007) The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 30(2):257–262. https://doi.org/10.2337/dc06-1240
Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151(2):190–198. https://doi.org/10.1093/oxfordjournals.aje.a010187
Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5(3):167–179. https://doi.org/10.1016/j.cmet.2007.01.002
Hyotylainen T, Jerby L, Petaja EM et al (2016) Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat Commun 7:8994. https://doi.org/10.1038/ncomms9994
Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(7):2005–2011. https://doi.org/10.2337/diabetes.51.7.2005
Jo J, Gavrilova O, Pack S et al (2009) Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 5(3):e1000324. https://doi.org/10.1371/journal.pcbi.1000324
Johannsen DL, Tchoukalova Y, Tam CS et al (2014) Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis. Diabetes Care 37(10):2789–2797. https://doi.org/10.2337/dc14-0761
Kahn D, Perreault L, Macias E et al (2021) Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans. Diabetologia 64(1):168–180. https://doi.org/10.1007/s00125-020-05315-0
Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7):2402–2410. https://doi.org/10.1210/jcem.85.7.6661
Kelley D, Mitrakou A, Marsh H et al (1988) Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81(5):1563–1571. https://doi.org/10.1172/JCI113489
Kim JY, van de Wall E, Laplante M et al (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117(9):2621–2637. https://doi.org/10.1172/JCI31021
Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M (2010) Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 59(2):299–304. https://doi.org/10.1016/j.metabol.2009.07.027
Kissebah AH, Vydelingum N, Murray R et al (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54(2):254–260. https://doi.org/10.1210/jcem-54-2-254
Kolak M, Westerbacka J, Velagapudi VR et al (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56(8):1960–1968. https://doi.org/10.2337/db07-0111
Krook A, Bjornholm M, Galuska D et al (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49(2):284–292. https://doi.org/10.2337/diabetes.49.2.284
Kurek K, Miklosz A, Lukaszuk B, Chabowski A, Gorski J, Zendzian-Piotrowska M (2015) Inhibition of ceramide de novo synthesis ameliorates diet induced skeletal muscles insulin resistance. J Diabetes Res 2015:154762. https://doi.org/10.1155/2015/154762
Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC (1996) Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98(2):378–385. https://doi.org/10.1172/JCI118803
Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541–551. https://doi.org/10.1016/S0140-6736(17)33102-1
Lean MEJ, Leslie WS, Barnes AC et al (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 7(5):344–355. https://doi.org/10.1016/S2213-8587(19)30068-3
Liebisch G, Fahy E, Aoki J et al (2020) Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures. J Lipid Res 61(12):1539–1555. https://doi.org/10.1194/jlr.S120001025
Liggi S, Griffin JL (2017) Metabolomics applied to diabetes-lessons from human population studies. Int J Biochem Cell Biol 93:136–147. https://doi.org/10.1016/j.biocel.2017.10.011
Linge J, Heymsfield SB, Dahlqvist Leinhard O (2020) On the definition of sarcopenia in the presence of aging and obesity-initial results from UK Biobank. J Gerontol A Biol Sci Med Sci 75(7):1309–1316. https://doi.org/10.1093/gerona/glz229
Listenberger LL, Han X, Lewis SE et al (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100(6):3077–3082. https://doi.org/10.1073/pnas.0630588100
Lomonaco R, Ortiz-Lopez C, Orsak B et al (2012) Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55(5):1389–1397. https://doi.org/10.1002/hep.25539
Luukkonen PK, Zhou Y, Sadevirta S et al (2016) Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 64(5):1167–1175. https://doi.org/10.1016/j.jhep.2016.01.002
Luukkonen PK, Sadevirta S, Zhou Y et al (2018) Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 41(8):1732–1739. https://doi.org/10.2337/dc18-0071
Mack E, Ziv E, Reuveni H et al (2008) Prevention of insulin resistance and beta-cell loss by abrogating PKCepsilon-induced serine phosphorylation of muscle IRS-1 in Psammomys obesus. Diabetes Metab Res Rev 24(7):577–584. https://doi.org/10.1002/dmrr.881
Magkos F, Fraterrigo G, Yoshino J et al (2016) Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 23(4):591–601. https://doi.org/10.1016/j.cmet.2016.02.005
Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24(3):539–548
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470. https://doi.org/10.2337/diacare.22.9.1462
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
McQuaid SE, Hodson L, Neville MJ et al (2011) Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60(1):47–55. https://doi.org/10.2337/db10-0867
Medina-Gomez G, Gray SL, Yetukuri L et al (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3(4):e64. https://doi.org/10.1371/journal.pgen.0030064
Mileti E, Kwok KH, Andersson DP et al (2021) Human white adipose tissue displays selective insulin resistance in the obese state. Diabetes. https://doi.org/10.2337/db21-0001
Mitrakou A, Kelley D, Veneman T et al (1990) Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39(11):1381–1390. https://doi.org/10.2337/diab.39.11.1381
Mittendorfer B, Yoshino M, Patterson BW, Klein S (2016) VLDL triglyceride kinetics in Lean, overweight, and obese men and women. J Clin Endocrinol Metab 101(11):4151–4160. https://doi.org/10.1210/jc.2016-1500
Mota M, Banini BA, Cazanave SC, Sanyal AJ (2016) Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism 65(8):1049–1061. https://doi.org/10.1016/j.metabol.2016.02.014
Perry RJ, Camporez JG, Kursawe R et al (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160(4):745–758. https://doi.org/10.1016/j.cell.2015.01.012
Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98(4):2133–2223. https://doi.org/10.1152/physrev.00063.2017
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54(3):603–608. https://doi.org/10.2337/diabetes.54.3.603
Petkevicius K, Virtue S, Bidault G et al (2019) Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity. Elife 8. https://doi.org/10.7554/eLife.47990
Phillips DI, Caddy S, Ilic V et al (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45(8):947–950. https://doi.org/10.1016/s0026-0495(96)90260-7
Pietilainen KH, Rog T, Seppanen-Laakso T et al (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9(6):e1000623. https://doi.org/10.1371/journal.pbio.1000623
Polyzos SA, Perakakis N, Mantzoros CS (2019) Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement. Metabolism 96:66–82. https://doi.org/10.1016/j.metabol.2019.05.001
Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118(3):829–838. https://doi.org/10.1172/JCI34275
Powell DJ, Hajduch E, Kular G, Hundal HS (2003) Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 23(21):7794–7808. https://doi.org/10.1128/MCB.23.21.7794-7808.2003
Puri P, Baillie RA, Wiest MM et al (2007) A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46(4):1081–1090. https://doi.org/10.1002/hep.21763
Ranganathan G, Unal R, Pokrovskaya I et al (2006) The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47(11):2444–2450. https://doi.org/10.1194/jlr.M600248-JLR200
Roden M, Stingl H, Chandramouli V et al (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49(5):701–707
Rosso C, Mezzabotta L, Gaggini M et al (2016) Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. Hepatology 63(1):107–116. https://doi.org/10.1002/hep.28287
Rosso C, Kazankov K, Younes R et al (2019) Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. J Hepatol 71(5):1012–1021. https://doi.org/10.1016/j.jhep.2019.06.031
Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148(5):852–871. https://doi.org/10.1016/j.cell.2012.02.017
Samuel VT, Shulman GI (2018) Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab 27(1):22–41. https://doi.org/10.1016/j.cmet.2017.08.002
Samuel VT, Liu ZX, Wang A et al (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117(3):739–745. https://doi.org/10.1172/JCI30400
Simon TG, Roelstraete B, Khalili H, Hagstrom H, Ludvigsson JF (2020) Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut. https://doi.org/10.1136/gutjnl-2020-322786
Sondergaard E, Espinosa De Ycaza AE, Morgan-Bathke M, Jensen MD (2017) How to measure adipose tissue insulin sensitivity. J Clin Endocrinol Metab 102(4):1193–1199. https://doi.org/10.1210/jc.2017-00047
Spalding KL, Arner E, Westermark PO et al (2008) Dynamics of fat cell turnover in humans. Nature 453(7196):783–787. https://doi.org/10.1038/nature06902
Stenberg E, Thorell A (2020) Insulin resistance in bariatric surgery. Curr Opin Clin Nutr Metab Care 23(4):255–261. https://doi.org/10.1097/MCO.0000000000000657
Stratford S, DeWald DB, Summers SA (2001) Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation. Biochem J 354(Pt 2):359–368. https://doi.org/10.1042/0264-6021:3540359
Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23(3):295–301. https://doi.org/10.2337/diacare.23.3.295
Szendroedi J, Yoshimura T, Phielix E et al (2014) Role of diacylglycerol activation of PKCtheta in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 111(26):9597–9602. https://doi.org/10.1073/pnas.1409229111
Ter Horst KW, Gilijamse PW, Versteeg RI et al (2017) Hepatic diacylglycerol-associated protein kinase Cepsilon translocation links hepatic steatosis to hepatic insulin resistance in humans. Cell Rep 19(10):1997–2004. https://doi.org/10.1016/j.celrep.2017.05.035
Thamer C, Machann J, Stefan N et al (2007) High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity 15(2):531–538. https://doi.org/10.1038/oby.2007.568
Trites MJ, Clugston RD (2019) The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice. Lipids Health Dis 18(1):204. https://doi.org/10.1186/s12944-019-1151-z
Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20(4):678–686. https://doi.org/10.1016/j.cmet.2014.08.002
van Vliet S, Koh HE, Patterson BW et al (2020) Obesity is associated with increased basal and postprandial beta-cell insulin secretion even in the absence of insulin resistance. Diabetes. https://doi.org/10.2337/db20-0377
Vangipurapu J, Stancakova A, Kuulasmaa T et al (2011) A novel surrogate index for hepatic insulin resistance. Diabetologia 54(3):540–543. https://doi.org/10.1007/s00125-010-1966-7
Yang K, Han X (2016) Lipidomics: techniques, applications, and outcomes related to biomedical sciences. Trends Biochem Sci 41(11):954–969. https://doi.org/10.1016/j.tibs.2016.08.010
Yang J, Eliasson B, Smith U, Cushman SW, Sherman AS (2012) The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity 20(5):932–938. https://doi.org/10.1038/oby.2011.371
Yki-Jarvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2(11):901–910. https://doi.org/10.1016/S2213-8587(14)70032-4
Zimmermann R, Strauss JG, Haemmerle G et al (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306(5700):1383–1386. https://doi.org/10.1126/science.1100747
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocciaro, G., Gastaldelli, A. (2022). Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction. In: Eckel, J., Clément, K. (eds) From Obesity to Diabetes. Handbook of Experimental Pharmacology, vol 274. Springer, Cham. https://doi.org/10.1007/164_2021_573
Download citation
DOI: https://doi.org/10.1007/164_2021_573
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-99994-0
Online ISBN: 978-3-030-99995-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)